The Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Stimulates Mechanistic Target of Rapamycin (mTOR) Signaling via PKA And Akt

Glucagon-like peptide 1 receptor (GLP-1R) agonists enhance glucose-stimulated insulin secretion and act on several regions of the brain to reduce food intake and body weight, making the GLP-1R a major therapeutic target for the treatment of type 2 diabetes and obesity. Surprisingly, little is known...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Thao D V, Liu, Dianxin, Collins, Sheila, Ayala, Julio E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Genetics and Development (including Gene Regulation)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090693/
http://dx.doi.org/10.1210/jendso/bvab048.1044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090693/
http://dx.doi.org/10.1210/jendso/bvab048.1044

Ejemplares similares